Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Equillium (EQ) Current Deferred Revenue (2022 - 2024)

Equillium (EQ) has disclosed Current Deferred Revenue for 3 consecutive years, with $2.1 million as the latest value for Q3 2024.

  • On a quarterly basis, Current Deferred Revenue fell 86.94% to $2.1 million in Q3 2024 year-over-year; TTM through Sep 2024 was $2.1 million, a 86.94% decrease, with the full-year FY2023 number at $15.7 million, up 7.0% from a year prior.
  • Current Deferred Revenue was $2.1 million for Q3 2024 at Equillium, down from $8.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $15.8 million in Q3 2023 to a low of $2.1 million in Q3 2024.
  • A 3-year average of $12.4 million and a median of $14.5 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: grew 7.0% in 2023, then plummeted 86.94% in 2024.
  • Equillium's Current Deferred Revenue stood at $14.7 million in 2022, then increased by 7.0% to $15.7 million in 2023, then crashed by 86.85% to $2.1 million in 2024.
  • Per Business Quant, the three most recent readings for EQ's Current Deferred Revenue are $2.1 million (Q3 2024), $8.4 million (Q2 2024), and $13.4 million (Q1 2024).